Prognostic Significance of Focal Lesions in Whole-Body Magnetic Resonance Imaging in Patients With Asymptomatic Multiple Myeloma

Department of Hematology and Oncology, University Hospital Heidelberg, Heidelberg, Germany.
Journal of Clinical Oncology (Impact Factor: 18.43). 02/2010; 28(9):1606-10. DOI: 10.1200/JCO.2009.25.5356
Source: PubMed


With whole-body magnetic resonance imaging (wb-MRI), almost the whole bone marrow compartment can be examined in patients with monoclonal plasma cell disease. Focal lesions (FLs) detected by spinal MRI have been of prognostic significance in symptomatic multiple myeloma (sMM). In this study, we investigated the prognostic significance of FLs in wb-MRI in patients with asymptomatic multiple myeloma (aMM).
Wb-MRI was performed in 149 patients with aMM. The prognostic significance of the presence and absence, as well as the number, of FLs for progression into sMM was analyzed.
FLs were present in 28% of patients. The presence per se of FLs and a number of greater than one FL were the strongest adverse prognostic factors for progression into sMM (P < .001) in multivariate analysis. A diffuse infiltration pattern in MRI, a monoclonal protein of 40 g/L or greater, and a plasma cell infiltration in bone marrow of 20% or greater were other adverse prognostic factors for progression-free survival in univariate analysis.
We recommend use of wb-MRI for risk stratification of patients with asymptomatic multiple myeloma.

Download full-text


Available from: Stefan Delorme,
  • Source
    • "18 F-FDG PET/CT is a modality that is sensitive in detecting osseous lesions and can differentiate between active and inactive MM lesions, serving therefore as a powerful treatment response evaluation tool [3] [7] [8] [9] [10] [11]. Moreover, focal lesions detected by PET/CT or MRI are of prognostic significance in all stages of monoclonal plasma cell disease [5] [11] [12]. However, to date, no routine use of 18 F-FDG PET in MM outside of clinical trials is recommended [13] [14]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: PET/MRI represents a promising hybrid imaging modality with several potential clinical applications. Although PET/MRI seems highly attractive in the diagnostic approach of multiple myeloma (MM), its role has not yet been evaluated. The aims of this prospective study are to evaluate the feasibility of (18)F-FDG PET/MRI in detection of MM lesions, and to investigate the reproducibility of bone marrow lesions detection and quantitative data of (18)F-FDG uptake between the functional (PET) component of PET/CT and PET/MRI in MM patients. The study includes 30 MM patients. All patients initially underwent (18)F-FDG PET/CT (60 min p.i.), followed by PET/MRI (120 min p.i.). PET/CT and PET/MRI data were assessed and compared based on qualitative (lesion detection) and quantitative (SUV) evaluation. The hybrid PET/MRI system provided good image quality in all cases without artefacts. PET/MRI identified 65 of the 69 lesions, which were detectable with PET/CT (94.2%). Quantitative PET evaluations showed the following mean values in MM lesions: SUVaverage=5.5 and SUVmax=7.9 for PET/CT; SUVaverage=3.9 and SUVmax=5.8 for PET/MRI. Both SUVaverage and SUVmax were significantly higher on PET/CT than on PET/MRI. Spearman correlation analysis demonstrated a strong correlation between both lesional SUVaverage (r=0.744) and lesional SUVmax (r=0.855) values derived from PET/CT and PET/MRI. Regarding detection of myeloma skeletal lesions, PET/MRI exhibited equivalent performance to PET/CT. In terms of tracer uptake quantitation, a significant correlation between the two techniques was demonstrated, despite the statistically significant differences in lesional SUVs between PET/CT and PET/MRI.
    American Journal of Nuclear Medicine and Molecular Imaging 11/2015; 5(5):469-78. · 3.25 Impact Factor
  • Source
    • "Moulopoulos et al (1995) reported that patients with conventionally defined asymptomatic MM and abnormal MRI findings progressed to symptomatic disease more quickly than those with normal MRI. In a recent report on 149 patients with smouldering MM, the presence of FLs on WB-MRI was the strongest adverse prognostic factor for subsequent progression to symptomatic MM (Hillengass et al, 2010). In the light of such observations, (WB)-MRI should be planned in patients with smouldering MM, as it may help assess the risk of progression and lead to a better definition of symptomatic disease (Table I). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Bone disease is the major feature of multiple myeloma (MM). Imaging is required for correct staging, in the follow-up after treatment and, as recently highlighted, is predictor of prognosis. In the near future, whole-body X-Ray may be replaced by more sensitive techniques, such as whole-body low-dose computerized tomography (CT). Magnetic resonance imaging (MRI) is the gold standard method for assessing bone marrow infiltration of the spine, predicting the risk of vertebral fracture and distinguishing between benign and malignant osteoporosis. Positron emission tomography (PET) with CT (PET/CT) provides important information about the extent of whole-body disease, including soft tissue masses, and is the best tool to distinguish between active or inactive disease after therapy. Both MRI and PET/CT are predictors of clinical outcome. A prospective use of these newer imaging techniques in both clinical trials and clinical practice may help optimize MM management in the near future.
    British Journal of Haematology 08/2012; 159(5). DOI:10.1111/bjh.12007 · 4.71 Impact Factor
  • Source
    • "The prognostic significance of the number and presence of those lesions has been shown recently (Hillengass, et al 2010, Walker, et al 2007). Diffuse infiltration, which can be detected in nearly the same proportion of patients, has also been demonstrated to be of prognostic as well as pathophysiologic significance (Hillengass, et al 2010, Moulopoulos, et al 2010, Moulopoulos, et al 2005), but it is hard to assess and impossible to quantify. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Bone marrow plasma cell infiltration is a crucial parameter of disease activity in monoclonal plasma cell disorders. Until now, the only way to quantify such infiltration was bone marrow biopsy or aspiration. Diffusion-weighted imaging (DWI) is a magnetic resonance imaging-technique that may mirror tissue cellularity by measuring random movements of water molecules. To investigate if DWI is capable of assessing bone marrow cellularity in monoclonal plasma cell disease, we investigated 56 patients with multiple myeloma or monoclonal gammopathy of undetermined significance, and 30 healthy controls using DWI of the pelvis and/or the lumbar spine. In 25 of 30 patients who underwent biopsy, bone marrow trephine and DWI could be compared. Of the patients with symptomatic disease 15 could be evaluated after systemic treatment. There was a positive correlation between the DWI-parameter apparent diffusion coefficient (ADC) and bone marrow cellularity as well as micro-vessel density (P<0·001 respectively). ADC was significantly different between patients and controls (P<0·01) and before and after systemic therapy (P<0·001). In conclusion, DWI enabled bone marrow infiltration to be monitored in a non-invasive, quantitative way, suggesting that after further investigations on larger patient groups this might become an useful tool in the clinical work-up to assess tumour burden.
    British Journal of Haematology 06/2011; 153(6):721-8. DOI:10.1111/j.1365-2141.2011.08658.x · 4.71 Impact Factor
Show more